Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Arvind Remedies Limited (NSE: ARVINDREM)

 
ARVINDREM Technical Analysis
1
As on N/A ARVINDREM SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ARVINDREMSHARE Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A | 52 Week Low N/A
 
NSE INDIA Most Active Stocks
IDEA 12.90 -2.27%
YESBANK 23.95 0.21%
GTLINFRA 1.75 0.00%
NHPC 87.15 -2.63%
TATASTEEL 162.10 1.28%
SUZLON 39.35 -4.37%
INDUSTOWER 351.40 2.03%
PNB 128.25 -1.00%
SAIL 146.05 0.86%
ZOMATO 189.20 2.16%
 
NSE INDIA Top Gainers Stocks
KMSUGAR 42.45 17.75%
SOLARA 551.75 16.45%
HINDMOTORS 23.70 15.61%
FORCEMOT 9313.85 15.47%
DSSL 1440.95 15.40%
ADFFOODS 215.50 14.29%
CELEBRITY 20.55 11.68%
KSCL 756.80 10.47%
INDOTECH 1732.90 10.00%
HIRECT 737.35 9.99%
 
NSE INDIA Top Losers Stocks
EXCEL 0.50 -9.09%
ANMOL 42.25 -7.85%
SHARDAMOTR 1504.15 -5.41%
TATACOMM 1755.20 -5.33%
JUBLPHARMA 665.00 -5.09%
ARENTERP 52.10 -5.01%
PVP 31.30 -5.01%
PVP 31.30 -5.01%
ARVEE 237.35 -5.00%
GKWLIMITED 2531.05 -5.00%
 
 
ARVINDREM
Daily Charts		 ARVINDREM
Intraday Charts		 Whats New @
Bazaartrend		 ARVINDREM
Free Analysis
 
ARVINDREM Important Levels Intraday
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
 
ARVINDREM Target April 2024
Share
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
ARVINDREM Weekly Target
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
ARVINDREM Target2024
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
Arvind Remedies Limited ( NSE INDIA Symbol : ARVINDREM )
Sector : Pharmaceuticals And Other Stocks in Same Sector
 
ARVINDREM Synopsis Technicals View
50 Day EMA N/A (Short Term)
 N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
 
ARVINDREM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website >
 
ARVINDREM Address
ARVINDREM
 N/A
 
ARVINDREM Latest News
 
Your Comments and Response on Arvind Remedies Limited
 
ARVINDREM Business Profile
Arvind Remedies is in the Pharmaceuticals sector. Arvind Remedies Ltd forayed into the world of quality healthcare in 1988 under the dynamic and ambitious stewardship of Dr.Arvind Shah, Managing Director and CEO. Having established our credibility as a company committed to providing world-class healthcare products, we went Public in April 1996 getting listed in Bombay Stock Exchange & National Stock Exchange in Mumbai, Ahmedabad and Chennai Stock Exchanges. The Public Issue comprised of 30 Lakhs Equity Shares priced at Rs.10/- each at a premium of Rs.20/- per share. In the year 1995 the company was converted to limited company. In January 2001, the Company followed this up with a Rights Issue of 14.86 Lakhs Equity Shares of Rs.10/- each for cash at a premium of Rs.90/- per share. During the year 2010-11 the company has increased its authorized share capital to Rs.66 Crores and paid up capital for Rs.48.23 crores with the addition of preferential issue of 22.50 crores equity shares of Rs.1 each at premium of Rs.1.25 per share. During the year 2012-13 company has started commercial operation of its new facility at irungatukottai,Kancheepuram Dt,Tamil nadu , which is plan for registration under USFDA Arvind Remedies' Indian client portfolio includes prestigious Defence Establishments, ESI, CGHS, Central and State Government Institutions, Public Sector Companies, P&T, Railways and World Bank Projects. We have also won international acceptance and recognition with our exports to Africa, Commonwealth of Independent States and Asian countries The current market capitalisation stands at Rs 307.14 crore.The company has reported a standalone sales of Rs 219.65 crore and a Net Profit of Rs 13.13 crore for the quarter ended Sep 2013. The company management includes B Arvind Shah - Managing Director & CEO, Chandra Ravindran - Whole Time Director, C M K Reddy - Director, R Raja Mohan - Director, V R Mehta - Director, Ankur Agarwal - Executive Director, Sudhir Chandra - Additional Director. It is listed on the BSE with a BSE Code of 531823 and the NSE with an NSE Code of ARVINDREM. Its Registered office is at 190, Poonamallee High Road , Chennai (Madras),Tamil Nadu - 600084.
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service